1 of 1
Story summary
- U.S. District Judge James V. Selna denied Apple’s request to overturn a $634 million verdict, upholding the jury’s infringement finding.
- The November 2025 jury concluded that Apple Watch heart-rate monitoring and notification features infringed Masimo’s pulse-oximetry patent.
- Apple said Masimo does not sell consumer products, its patents have been invalidated, and the patent expired in 2022.
- Apple announced it will appeal the ruling.
